Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

SWK Holdings Corp (SWKH) > Segments

Pharmaceutical Development

Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues     0.6    
Research and development     1.2    
General and administrative     1.2    
EBITDA     4.9    
            EBITDA margin     794.8%    
Depreciation and amortization     4.9    
   
Revenue Mix     2.0%    

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy